ArticleCureus2026
Vitamin D Status and Test Utilization: A Five-Year Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Vitamin D testing has increased markedly over the past decade, often exceeding evidence-based recommendations that discourage routine screening in low-risk populations. This growing demand has raised concerns regarding test overutilization, misalignment with clinical indications, and the uncertain impact on patient management. This study aimed to assess vitamin D status, clinical indications for testing, and associated comorbidities over a five-year period in North Batinah, Oman, while evaluating the clinical utility of vitamin D testing in routine practice. Methodology A retrospective cross-sectional study included all vitamin D requests by the primary healthcare institutes sent to Sohar Hospital, the sole regional laboratory providing serum 25-hydroxyvitamin D (25(OH)D) testing. All Omani and non-Omani residents who underwent testing between January 2018 and November 2022 were included. Vitamin D status was classified as deficient (<30 nmol/L), insufficient (30-50 nmol/L), or sufficient (>50 nmol/L). Demographic variables, documented clinical indications, and comorbidities, including diabetes mellitus, hypertension, anemia, chronic kidney disease, and hypothyroidism, were analyzed, alongside temporal trends in testing patterns. Results A total of 3,081 patients were included, predominantly women and Omani nationals. Overall, vitamin D sufficiency was high across the cohort. However, vitamin D insufficiency was more prevalent among younger and middle-aged adults, particularly women, whereas older adults demonstrated higher sufficiency rates. Pediatric vitamin D deficiency was uncommon, though adolescents showed increased rates of insufficiency. A substantial proportion of vitamin D test requests were not aligned with guideline-supported clinical indications. Among individuals with low vitamin D levels, anemia, hypertension, and hypothyroidism were the most frequently observed comorbidities, while diabetes mellitus did not demonstrate a strong association. Conclusion Despite increasing testing volumes, clinically significant vitamin D deficiency was relatively uncommon, suggesting the potential overutilization of testing. These findings highlight the need for targeted, indication-based vitamin D testing strategies and strengthened laboratory stewardship to improve clinical value and optimize healthcare resource utilization.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.